Erwan Bezard

Université de Bordeaux, Talence, Nouvelle-Aquitaine, France 
neurodegenerative disorders
"Erwan Bezard"

Bezard has authored or co-authored over 90 professional publications in the field of neurobiology, most of which are on Parkinson's disease and related disorders. He is perhaps best known for the reappraisal of both the identification of the nature of compensatory mechanisms that mask the progression Parkinson's disease and their sequential activation in non-human primate models that mimic Parkinson’s progression. His current research interests include the study of the compensatory mechanisms, the levodopa-induced dyskinesia, the basic pathophysiology of basal ganglia circuitry, and the development of new strategies to alleviate symptoms and/or to slow disease progression.

(Show more)

Mean distance: 15.8 (cluster 6)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Meissner WG, Fernagut PO, Dehay B, et al. (2019) Multiple System Atrophy: Recent Developments and Future Perspectives. Movement Disorders : Official Journal of the Movement Disorder Society
Dehay B, Bezard E. (2019) Intrastriatal injection of alpha-synuclein fibrils induces Parkinson-like pathology in macaques. Brain : a Journal of Neurology. 142: 3321-3322
Mercatelli D, Bezard E, Eleopra R, et al. (2019) Managing Parkinson's disease: Moving ON with NOP. British Journal of Pharmacology
Shariatgorji M, Nilsson A, Fridjonsdottir E, et al. (2019) Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging. Nature Methods
Arotcarena ML, Bourdenx M, Dutheil N, et al. (2019) Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies. Jci Insight. 4
Ribot B, Aupy J, Vidailhet M, et al. (2019) Dystonia and dopamine: From phenomenology to pathophysiology. Progress in Neurobiology. 101678
Rosenblad C, Li Q, Pioli EY, et al. (2019) Vector-mediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson's disease. Brain : a Journal of Neurology
Nuzzo T, Punzo D, Devoto P, et al. (2019) The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patients. Scientific Reports. 9: 8898
Delamarre A, Tison F, Li Q, et al. (2019) Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996)
Li Q, Fernagut PO, Bezard E. (2019) l-Dopa-free learned dyskinetic behavior in a Parkinson's primate model. Movement Disorders : Official Journal of the Movement Disorder Society
See more...